Search Results

You are looking at 201 - 210 of 1,362 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Seyed M. Qaderi, Paul W. Dickman, Johannes H.W. de Wilt, and Rob H.A. Verhoeven

data from the Netherlands Cancer Registry (NCR). 13 All patients newly diagnosed with cancer are registered in the nationwide NCR. Information regarding patient and tumor characteristics are extracted directly from medical records by trained NCR data

Full access

Jason Hu, Armen G. Aprikian, Marie Vanhuyse, and Alice Dragomir

,586). Results Cohort Characteristics A total of 22,033 patients were included in the cohort with a mean age of 75 years. Prior diagnosis of osteoporosis and use of bisphosphonates were found in 1.2% and 6.3% of the cohort, respectively. Most patients were

Full access

Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Yang Li, Qing-Nan Tang, Xue-Song Sun, Yu-Jing Liang, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma, and Hai-Qiang Mai

antigen immunoglobulin A. Tests were 2-sided, and a P value <.05 was considered significant. Results The characteristics of the 2,263 patients in the different treatment groups are presented in Table 1 . In the NACT + CCRT group (N=1,073), 81.5% of

Full access

Elio Mazzone, Sophie Knipper, Francesco A. Mistretta, Carlotta Palumbo, Zhe Tian, Andrea Gallina, Derya Tilki, Shahrokh F. Shariat, Francesco Montorsi, Fred Saad, Alberto Briganti, and Pierre I. Karakiewicz

.29). 14 , 18 Only patients with a secondary diagnosis of metastatic disease were included (ICD-9-CM codes 197.x and 198.x). These selection criteria yielded 1,944 patients. Patient and Hospital Characteristics Patient age at admission, year of admission

Full access

Arjun Gupta, Raseen Tariq, Ryan D. Frank, Gary W. Jean, Muhammad S. Beg, Darrell S. Pardi, David H. Johnson, and Sahil Khanna

accessible online at http://www.cdc.gov/nchs/nhds.htm . All diagnoses are based on ICD-9-CM codes. Data Collection Data collected and analyzed included age, sex, race, admission type (urgent/emergent vs elective), hospital characteristics, LOS

Full access

Areej El-Jawahri, Deborah Forst, Alyssa Fenech, Keri O. Brenner, Amanda L. Jankowski, Lauren Waldman, Isabella Sereno, Ryan Nipp, Joseph A. Greer, Lara Traeger, Vicki Jackson, and Jennifer Temel

, relationship status, or time since diagnosis of incurable cancer and patient-reported QoL or mood. Table 1. Participant Characteristics Patients’ Perceptions of Both Their Treatment Goal and Their Oncologist’s Goal Figure 1 depicts patients’ perceptions of

Full access

Angela K. Green, Deborah Korenstein, Carol Aghajanian, Brooke Barrow, Michael Curry, and Roisin E. O’Cearbhaill

patients who underwent SCS by imaging practices. Characteristics between patients treated by high- versus low-frequency imaging providers were compared using chi-square tests for discrete variables and t tests for continuous variables. Because CA-125

Full access

Ya-Fu Cheng, Wei-Heng Hung, Heng-Chung Chen, Ching-Yuan Cheng, Ching-Hsiung Lin, Sheng-Hao Lin, and Bing-Yen Wang

excluded if they received no therapy or if their database records were missing values for therapy or type of surgery. Baseline patient demographics (age and sex), tumor characteristics (histologic grade, cell type, T stage), and treatment details (surgery

Full access

Rongbo Lin, Jinfeng Zhu, Yushuang Luo, Xia Lv, Mingqian Lu, Haihui Chen, Huichao Zou, Zhichun Zhang, Shaowei Lin, Milu Wu, Xiaofeng Li, Min Zhou, Shen Zhao, Liyu Su, Jiang Liu, and Cheng Huang

or avNRS among the 3 arms ( Table 1 ). Other baseline characteristics were well balanced between the 3 groups, with comparable ESAS symptom severity ( supplemental eTable 2 and Table 1 ). Figure 1. Study profile. (A1) Bolus-only arm, (A2

Full access

Matthew H. Kulke, Al B. Benson III, Emily Bergsland, Jordan D. Berlin, Lawrence S. Blaszkowsky, Michael A. Choti, Orlo H. Clark, Gerard M. Doherty, James Eason, Lyska Emerson, Paul F. Engstrom, Whitney S. Goldner, Martin J. Heslin, Fouad Kandeel, Pamela L. Kunz, Boris W. Kuvshinoff II, Jeffrey F. Moley, Venu G. Pillarisetty, Leonard Saltz, David E. Schteingart, Manisha H. Shah, Stephen Shibata, Jonathan R. Strosberg, Jean-Nicolas Vauthey, Rebekah White, James C. Yao, Deborah A. Freedman-Cass, and Mary A. Dwyer

< 5% of patients) are not specifically discussed in these guidelines. Histologic Classification and Staging of Neuroendocrine Tumors Neuroendocrine tumors are generally subclassified by site of origin and histologic characteristics. Pancreatic